The clinical and cost effectiveness of a Breathlessness Intervention Service for patients with advanced non-malignant disease and their informal carers: mixed findings of a mixed method randomised controlled trial

Morag C Farquhar, A Toby Prevost, Paul McCrone, Barbara Brafman-Price, Allison Bentley, Irene J Higginson, Chris J Todd, Sara Booth, Morag C Farquhar, A Toby Prevost, Paul McCrone, Barbara Brafman-Price, Allison Bentley, Irene J Higginson, Chris J Todd, Sara Booth

Abstract

Background: Breathlessness is the most common and intrusive symptom of advanced non-malignant respiratory and cardiac conditions. The Breathlessness Intervention Service (BIS) is a multi-disciplinary complex intervention, theoretically underpinned by a palliative care approach, utilising evidence-based non-pharmacological and pharmacological interventions to support patients with advanced disease in managing their breathlessness. Having published the effectiveness and cost effectiveness of BIS for patients with advanced cancer and their carers, we sought to establish its effectiveness, and cost effectiveness, in advanced non-malignant conditions.

Methods: This was a single-centre Phase III fast-track single-blind mixed method RCT of BIS versus standard care for breathless patients with non-malignant conditions and their carers. Randomisation was to one of two groups (randomly permuted blocks). Eighty-seven patients referred to BIS were randomised (intervention arm n = 44; control arm n = 43 received BIS after four-week wait); 79 (91 %) completed to key outcome measurement. The primary outcome measure was 0-10 numeric rating scale for patient distress due to breathlessness at four weeks. Secondary outcome measures were Chronic Respiratory Questionnaire, Hospital Anxiety and Depression Scale, Client Service Receipt Inventory, EQ-5D and topic-guided interviews.

Results: Qualitative analyses showed the positive impact of BIS on patients with non-malignant conditions and their carers; quantitative analyses showed a non-significant greater reduction in the primary outcome ('distress due to breathlessness'), when compared to standard care, of -0.24 (95 % CI: -1.30, 0.82). BIS resulted in extra mean costs of £799, reducing to £100 when outliers were excluded; neither difference was statistically significant. The quantitative findings contrasted with those previously reported for patients with cancer and their carers, which showed BIS to be both clinically and cost effective. For patients with non-malignant conditions there was a notable trend of improvement over both trial arms to the key measurement point; participants may have experienced a therapeutic effect from the research interviews, diluting the intervention's impact.

Conclusions: BIS had a statistically non-significant effect for patients with non-malignant conditions, and slightly increased service costs, but had a qualitatively positive impact consistent with findings for advanced cancer. Trials of palliative care interventions should consider multiple, mixed method, primary outcomes and ensure that protocols limit potential contaminating therapeutic effects in study designs.

Trial registration: Current Controlled Trials ISRCTN04119516 (December 2008); ClinicalTrials.gov NCT00678405 (May 2008).

Keywords: Advanced disease; Breathlessness; Chronic obstructive pulmonary disease; Complex intervention; Mixed methods; Non-malignant disease; Palliative care; Randomised controlled trial.

Figures

Fig. 1
Fig. 1
CONSORT flow diagram

References

    1. Bailey PH. The dyspnea-anxiety-dyspnea cycle—COPD patients’ stories of breathlessness: “It’s scary/when you can’t breathe”. Qual Health Res. 2004;14(6):760–78. doi: 10.1177/1049732304265973.
    1. Seamark DA, Blake SD, Seamark CJ. Living with severe chronic obstructive pulmonary disease: perceptions of patients and their carers. Palliat Med. 2004;18(7):619–25. doi: 10.1191/0269216304pm928oa.
    1. Parshall MB, Schwartzstein RM, Adams L, Banzett RB, Manning HL, Bourbeau J, et al. An official American Thoracic Society statement: update on the mechanisms, assessment and management of dyspnea. Am J Respir Crit Care Med. 2012;185:435–52. doi: 10.1164/rccm.201111-2042ST.
    1. Gillespie DJ, Staats BA. Unexplained dyspnea. Mayo Clin Proc. 1994;69:657–63. doi: 10.1016/S0025-6196(12)61344-5.
    1. Gysels M, Bausewein C, Higginson IJ. Experiences of breathlessness: a systematic review of the qualitative literature. Palliat Supp Care. 2007;5:281–302.
    1. Roberts CM, Seiger A, Buckingham RJ, Stone RA. Clinician perceived good practice in end-of-life care for patients with COPD. Palliat Med. 2008;22:855–8. doi: 10.1177/0269216308096722.
    1. Partridge MR, Khatri A, Sutton L, Welham S, Afmedzai SH. Palliative care services for those with chronic lung disease. Chron Respir Dis. 2009;6:13–7. doi: 10.1177/1479972308100538.
    1. Buxton KL, Stone RA, Buckingham RJ, Pursey NA, Roberts CM. Current and planned palliative care service provision for chronic obstructive pulmonary disease patients in 239 UK hospital units: comparison with the gold standards framework. Palliat Med. 2010;24(5):480–5. doi: 10.1177/0269216310363650.
    1. Pinnock H, Kendall M, Murray SA, Worth A, Porter M, Mac Nee W, et al. Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ. 2011;342(d142):1–10.
    1. Bajwah S, Koffman J, Higginson IJ, Ross JR, Wells AU, Birring SS, et al. ‘I wish I knew more…’ the end-of life planning and information needs for end-stage fibrotic interstitial lung disease: views of patients, carers and healthcare professionals. BMJ Support Palliat Care. 2013;3(1):84–90. doi: 10.1136/bmjspcare-2012-000263.
    1. Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000;55:1000–6. doi: 10.1136/thorax.55.12.1000.
    1. Gysels M, Higginson IJ. Access to services for patients with chronic obstructive pulmonary disease: the invisibility of breathlessness. J Pain Symptom Manage. 2008;36:451–60. doi: 10.1016/j.jpainsymman.2007.11.008.
    1. Booth S, Moffat C, Farquhar M, et al. Developing a breathlessness service for patients with palliative and supportive care needs, irrespective of diagnosis. J Palliat Care. 2011;27(1):28–36.
    1. Booth S, Moffat C, Burkin J. The Cambridge BIS Manual – Building a Breathlessness Intervention Service. Cambridge: Cambridge University Hospitals NHS Foundation Trust; 2012.
    1. Breathless Intervention Service. . Accessed 18 July 2015.
    1. Booth S, Silvester S, Todd C. Breathlessness in cancer and chronic obstructive pulmonary disease: using a qualitative approach to describe the experience of patients and carers. Palliat Support Care. 2003;1(4):337–44. doi: 10.1017/S1478951503030499.
    1. Booth S, Farquhar M, Gysels M, Bausewein C, Higginson IJ. The impact of a breathlessness intervention service (BIS) on the lives of patients with intractable dyspnoea: a qualitative Phase I study. Palliat Support Care. 2006;4:287–93. doi: 10.1017/S1478951506060366.
    1. Farquhar M, Higginson IJ, Fagan P, Booth S. The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. BMC Palliat Care. 2009;8:9. doi: 10.1186/1472-684X-8-9.
    1. Farquhar M, Higginson IJ, Fagan P, Booth S. Results of a pilot investigation into a complex intervention for breathlessness in advanced chronic obstructive pulmonary disease (COPD): brief report. Palliat Support Care. 2010;8(2):143–9. doi: 10.1017/S1478951509990897.
    1. Farquhar M, Ewing G, Booth S. Using mixed methods to develop and evaluate complex interventions in palliative care research. Palliat Med. 2011;25(8):748–57. doi: 10.1177/0269216311417919.
    1. Farquhar M, Prevost AT, McCrone P, Brafman-Price B, Bentley A, Higginson IJ, et al. Is a specialist breathlessness service more effective and cost-effective for patients with advanced cancer and their carers than standard care? Findings of a mixed method randomised controlled trial. BMC Med. 2014;12:194. doi: 10.1186/s12916-014-0194-2.
    1. MRC . A framework for development and evaluation of RCTs for complex interventions to improve health. London: MRC; 2000.
    1. Farquhar M, Prevost AT, McCrone P, Higginson IJ, Gray J, Brafman-Kennedy B, et al. Study protocol: Phase III single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease. Trials. 2011;12:130. doi: 10.1186/1745-6215-12-130.
    1. Guyatt GH, Berman LB, Townsend M, Pugsley SO, Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987;42:773–8. doi: 10.1136/thx.42.10.773.
    1. Zigmond AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand. 1983;67:361–70. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Group EQL. EuroQoL - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. doi: 10.1016/0168-8510(90)90421-9.
    1. Beecham J, Knapp M. Costing psychiatric interventions. In: Thornicroft G, editor. Measuring mental health needs. 2. London: The Royal College of Psychiatrists; 2001. pp. 200–24.
    1. Curtis L. Unit costs of health and social care. Canterbury: PSSRU; 2012.
    1. Patton MQ. Qualitative evaluation and research methods. 2. Newbury Park, CA: Sage Publications; 1990.
    1. NVivo: the #1 software for qualitative data analysis. . Accessed 18 July 2015.
    1. Ritchie J, Spencer L. Qualitative data analysis for applied policy research. In: Bryman A, Burgess RG, editors. Analyzing qualitative data. London: Routledge; 1994. pp. 173–94.
    1. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001;40(4):429–34. doi: 10.1348/014466501163904.
    1. Higginson IJ, Bausewein C, Reilly CC, Gao W, Gysels M, Dzingina M, et al. An integrated palliative and respiratory care service for patients with advanced disease and refractory breathlessness: a randomised controlled trial. Lancet Respir Med. 2014;2(12):979–87. doi: 10.1016/S2213-2600(14)70226-7.
    1. Chowienczyk S, Javadzadeh S, Booth S, Farquhar M. Association of descriptors of breathlessness with diagnosis, self-reported severity of breathlessness and self-reported distress due to breathlessness in patients with advanced cancer or advanced COPD. J Pain Symptom Manage. 2016. (in press)
    1. Javadzadeh S, Chowienczyk S, Booth S, Farquhar M. Comparison of respiratory health-related quality of life in patients with intractable breathlessness due to advanced cancer or advanced COPD. BMJ Support Palliat Care. 2016;6:105–8. doi: 10.1136/bmjspcare-2015-000949.
    1. French DP, Sutton S. Reactivity of measurement in health psychology: how much of a problem is it? What can be done about it? Br J Health Psychol. 2010;15:453–68. doi: 10.1348/135910710X492341.
    1. Donovan DM, Bogenschutz MP, Perl H, Forcehimes A, Adinoff B, Mandler R, et al. Study design to examine the potential role of assessment reactivity in the Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED) protocol. Addict Sci Clin Prac. 2012;7:16. doi: 10.1186/1940-0640-7-16.
    1. Booth S, Chin C, Spathis A. The brain and breathlessness: understanding and disseminating a palliative care approach. Palliat Med. 2015;29(5):396–8. doi: 10.1177/0269216315579836.
    1. Gysels M, Shipman C, Higginson IJ. Is the qualitative research interview an acceptable medium for research in palliative care patients and carers? BMC Med Ethics. 2008;9:7. doi: 10.1186/1472-6939-9-7.
    1. Colbourne L, Sque M. The culture of cancer and the therapeutic effect of research interviews. J Nurs Res. 2005;10(5):551–67. doi: 10.1177/136140960501000501.
    1. Pessin H, Galietta M, Nelson CJ, Brescia R, Rosenfeld B, Breitbart W. Burden and benefit of psychosocial research at the end of life. J Pall Med. 2008;11(4):627–32. doi: 10.1089/jpm.2007.9923.
    1. Hall S, Goddard C, Speck PW, Martin P, Higginson IJ. “It makes you feel that somebody is out there caring”: a qualitative study of intervention and control participants’ perceptions of the benefits of taking part in an evaluation of dignity therapy for people with advanced cancer. J Pain Symptom Manage. 2013;45(4):712–25. doi: 10.1016/j.jpainsymman.2012.03.009.
    1. Hall AM, Ferriera PH, Maher CG, Ferriera ML. The influence of the therapist-patient relationship on treatment outcome in physical rehabilitation: a systematic review. Phys Ther. 2010;90(8):1099–110. doi: 10.2522/ptj.20090245.
    1. Weck F, Grikscheit F, Jakob M, Hofling V, Stangier U. Treatment failure in cognitive-behavioural therapy: therapeutic alliance as a precondition for an adherent and competent implementation of techniques. Br J Clin Psychol. 2015;54(1):91–108. doi: 10.1111/bjc.12063.
    1. Currow DC, Smith J, Davidson PM, Newton PJ, Agar MR, Abernethy AP. Do the trajectories of dyspnea differ in prevalence and intensity by diagnosis at the end of life? A consecutive cohort study. J Pain Symptom Manage. 2010;39(4):680–90. doi: 10.1016/j.jpainsymman.2009.09.017.
    1. Bausewein C, Booth S, Gysels M, Kϋhnbach R, Haberland B, Higginson IJ. Individual breathlessness trajectories do not match summary trajectories in advanced cancer and chronic obstructive pulmonary disease: results from a longitudinal study. Palliat Med. 2010;24(8):777–86. doi: 10.1177/0269216310378785.
    1. Wagner KD, Davidson PJ, Pollini RA, Strathdee SA, Washburn R, Palinkas LA. Reconciling incongruous qualitative and quantitative findings in mixed methods research: exemplars from research with drug using populations. Int J Drug Pol. 2012;23:54–61. doi: 10.1016/j.drugpo.2011.05.009.
    1. Moffatt S, White M, Mackintosh J, Howel D. Using quantitative and qualitative data in health services research – what happens when mixed method findings conflict? BMC Health Serv Res. 2006;6:28. doi: 10.1186/1472-6963-6-28.
    1. Carr-Hill RA. Allocating resources to health care: is the QALY (Quality Adjusted Life Year) a technical solution to a political problem? Int J Health Serv. 1991;21(2):351–63. doi: 10.2190/HPLM-EGXV-BWKY-5XBN.
    1. Cavendish M. Boy racer. New York: Random House; 2010.
    1. Richards DA. Complex interventions and the amalgamation of marginal gains: a way forward for understanding and researching essential nursing care? Int J Nurs Studies. 2015;52:1143–5. doi: 10.1016/j.ijnurstu.2015.01.013.
    1. Bausewein C, Daveson B, Benalia H, Simon ST, Higginson IJ. Outcome measurement in palliative care: the essentials. 2011.
    1. Normand C. Measuring outcomes in palliative care: limitations of QALYs and the road to PalYs. J Pain Symptom Manage. 2009;38(1):27–31. doi: 10.1016/j.jpainsymman.2009.04.005.
    1. Cawley D, Waterman D, Roberts D, Caress AL. A qualitative study exploring perceptions and experiences of patients and clinicians of palliative medicine outpatient clinics in different settings. Palliat Med. 2011;25:52–61. doi: 10.1177/0269216310375998.
    1. Rocker G. Dyspnea: recent insights and innovations. Prog Palliat Care. 2011;19(5):219–21. doi: 10.1179/174329111X13147108047456.
    1. Rocker G, Cook D. 'INSPIRED' approaches to better care for patients with advanced COPD. Clin Inest Med. 2013;36(3):E114–20.

Source: PubMed

赞助者和合作者

医疗条件

药物干预

3
订阅